Clinical Trials Sponsored by Eva Prescott

Total 5055 results

TVA Medical Inc.

Completed

Novel Endovascular Access Trial (NEAT) (NEAT)

Chronic Kidney Disease

Canada, Australia, New Zealand
ELA Medical, Inc.

Completed

OVATIO CRT and SITUS OTW LV Lead Post Approval Study

Heart Failure

United States
ELA Medical, Inc.

Completed

Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study (Post-Ovatio)

Sudden Cardiac Death

United States
Teva Pharmaceuticals USA

Completed

Clinical Equivalence Study of Mometasone Nasal Spray, 50 Mcg/Actuation

Seasonal Allergic Rhinitis
Teva Pharmaceuticals USA

Completed

Norethindrone/Ethinyl Estradiol 0.4 mg/35 Mcg Chewable Tablets Under Fasting Conditions

Bioequivalence

United States
Teva Pharmaceuticals USA

Completed

Venlafaxine Hydrochloride 150 mg Extended-Release Capsules Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

90 mg Fluoxetine Hydrochloride Capsules Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Losartan 100 mg Tablet in Healthy Subjects Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Bioavailability of Metronidazole Vaginal Gel in Healthy Subjects

Healthy

United States
Teva Pharmaceuticals USA

Completed

Tamsulosin Hydrochloride 0.4 mg Capsules Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Valacyclovir 1000 mg Tablet Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Pramipexole Dihydrochloride 0.25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Bioequivalence of Metronidazole Gel, 0.75% in the Treatment of Bacterial Vaginosis

Bacterial Vaginosis

United States
Teva Pharmaceuticals USA

Completed

Terbinafine HCl 250 mg Tablet Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Topiramate 25 mg Tablets Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Non-Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Pravastatin 80 mg Tablets Dosed in Healthy Subjects Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Oxcarbazepine 600 mg Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

5 mg Glipizide/500 mg Metformin Hydrochloride Tablets, Fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Granisetron 1 mg Tablets, Non-fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clarithromycin 500 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Mesalamine 4 gm/60 mL Rectal Enema

Healthy

United States
Teva Pharmaceuticals USA

Completed

Clindamycin 300 mg Capsules in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ribavirin 200 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium 500 mg Extended Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Study of Bicalutamide 1 x 50 mg Tablet in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

600 mg Amoxicillin/42.9 mg Clavulanate Postassium /5 mL Suspension Under Fed Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Ondansetron HCl Orally Disintegrating Tablets Under Non-Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Divalproex Sodium Delayed-Release Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefadroxil 500 mg Capsules Under Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Famciclovir 500 mg Tablets Under Non-Fasting Conditions

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefprozil for Oral Suspension 250 mg/5 mL, Non-fasting

Healthy

United States
Teva Pharmaceuticals USA

Completed

Cefadroxil 500 mg Capsules in Normal Healthy Non-Smoking Male and Female Subjects.

Healthy

United States, Canada
Teva Pharmaceuticals USA

Completed

Cefprozil 500 mg Tablets Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Doxycycline Monohydrate 25 mg (5mL) Oral Suspension Under Fed Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Amlodipine 10 mg Tablets Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Amoxicillin-Clavulanic Acid 400 mg-57 mg Chewable Tablets Under Non-Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Zaleplon 10mg Capsules Under Fasting Conditions

Healthy

United States
Teva Pharmaceuticals USA

Completed

Amlodipine-Benazepril 10mg-20mg Capsules in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fed

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Sertraline Hydrochloride 100 mg Tablets, Fasting

Healthy

Canada
Teva Pharmaceuticals USA

Completed

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

Healthy

Canada
Teva Pharmaceuticals USA
Teva Branded Pharmaceutical Products R&D, Inc.

Completed

A Study to Test if TVB-009P is Effective in Relieving Postmenopausal Osteoporosis

Osteoporosis, Postmenopausal

United States, Bulgaria, Czechia, Georgia, Germany, Hungary, Poland, Russian Federation, Slovakia, Ukraine
Teva Pharma GmbH

Completed

A Study to Evaluate the Effect of Ovaleap® on the Pregnancy Rate and Clinical Effects as Well as the User-friendliness of the Ovaleap®-Pen.

Pregnancy Rate | Oocytes

Germany
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact of Using Warm Compress Prior to Daily Injections of Copaxone®

Multiple Sclerosis

United States
Teva Neuroscience, Inc.

Completed

A Study to Evaluate the Impact on Skin (Injection Site) Reactions of Using Alcohol Wipes Prior to Daily Injections of Copaxone®.

Multiple Sclerosis

3

Subscribe